Announced
Synopsis
Patient Square Capital, a healthcare investment firm, agreed to acquire NanoString Technologies, a provider of life science tools for discovery and translational research for $220m “This agreement with Patient Square provides continuity for our scientific customers and employees, and represents an important step in our financial restructuring. We believe that Patient Square is committed to continuing NanoString’s mission to Map the Universe of Biology and is prepared to invest in our market-leading product roadmap,” Brad Gray, NanoString Technologies President & CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.